Roche Holding Ltd header image

Roche Holding Ltd

RO

Equity

ISIN CH0012032113 / Valor 1203211

SIX Swiss Exchange (2026-10-23)
CHF 397.40-0.15%

Roche Holding Ltd
UMushroom community rating:

star star star star star
4.36 17 votes No rating yet
NegativeNeutralPositive

About company

Roche Holding Ltd is a global healthcare company headquartered in Basel, Switzerland, renowned for its contributions to pharmaceuticals and diagnostics. The company is dedicated to developing innovative treatments across major disease areas, with a strong emphasis on translating scientific excellence into effective medicines. Roche's pharmaceutical division is particularly focused on oncology, immunology, infectious diseases, ophthalmology, and neuroscience, aiming to address unmet medical needs and improve patient outcomes. In addition to its pharmaceutical endeavors, Roche is a leader in in-vitro diagnostics and tissue-based cancer diagnostics, providing comprehensive solutions that enhance disease detection and management. Through its commitment to research and development, Roche continues to play a pivotal role in advancing healthcare and delivering transformative therapies worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

40.3%1Y
56.8%3Y
1.22%5Y

Performance

23.5%1Y
23.9%3Y
22.7%5Y

Volatility

Market cap

51166 M

Market cap (USD)

Daily traded volume (Shares)

25,455

Daily traded volume (Shares)

1 day high/low

268 / 264.4

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.36

17 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.36
Society:
starstarstarstarstar
4.20
Nature:
starstarstarstarstar
3.52
Alexander Priess
Switzerland, 22 Mar 2026
star star star star star
-.
Gabriele Di Benedetto
Switzerland, 01 Nov 2025
star star star star star
good security belonging to a safe 'place like Switzerland however the relationship between USA has been proven the Roche reality export so it's a tricky moment
Karel Bourban
Switzerland, 28 Oct 2025
star star star star star
Easy to follow

EQUITIES OF THE SAME SECTOR

Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%USD 13.40
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.73%CHF 94.20
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.46%SEK 300.00
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.01%USD 83.87
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.76%USD 93.39
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 36.13
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.07%USD 28.07
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.88%EUR 28.14
Inventiva SA
Inventiva SA Inventiva SA Valor: 35598121
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.45%EUR 3.06
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.08%EUR 143.30